AI- Health, Investment
£1 million- raise .
CREATING THE VERY BEST IN MOBILE HEALTH & FITNESS APPS
NICE TO MEET YOU, WE'RE AI-HEALTH
9 YEARS IN R&D. SELF-FUNDED. DEVELOPED 7 APPS FOR HEALTH & FITNESS.
Walking. Fitness. Female. Sleep. Running. Health. Coaches.
Our goal is simple. 87% of total mortality in the United States can be attributed to non-communicable disease. The numbers are very similar in the UK and they are getting much worse.
We have worked hard over the past nine yrs to offer a proven scientific intervention to help the global community reverse & prevent our most dangerous health pandemics, MetS, Over-Fat & CVD.
Our apps will help users become measurably fitter whilst regaining control over their metabolism, through a better understanding of carbohydrate /sugar consumption and over time, will result in stronger insulin sensitivity, which is a significant contributing factor to sustained weight loss and increased longevity.
-
2 Apps Live - 5 more ready to release.
-
Substantial & Fully Functional Free Apps Alongside; An AI subscription model that only offers a subscription plan if there is a clinical need ( high MetS RISK).
-
Validated Internal Algorithms & Data Accuracy to within 5% of science laboratory gold standard equipment in multiple science trials.
-
Randomised (5000) Beta Users showing high user weekly frequency (5/day-ave) and duration (30 min /ave-day) usage.
-
Support From Apple Global Innovation department during development and with Fitness PR at point of launch.
-
The company remains self funded and is Fully Debt Free.
Share Offer
£1m CAPITAL RAISE TO FUND
Marketing for subscription growth. Shares slots :
£5k /£35m val or
£25k /£30m val.
AI-Health Val £30m Oct 21. Expected £150m + Apr 25.
Product Proposition
7 HEALTH & FITNESS APPS
Developed & powered by the AI-Health Database Matrix.
Walk Ailly & Fitness Ailly are now live & in the app store.
Company is debt free.
Strategic Exit
ARR = £88m (mid 2025 )
Our sector shows strong precedents for lucrative exits.
Our financial calculations indicating hyper-scaling growth funded by revenue not debt
AI-HEALTH
SCALING & GROWTH
In contrast to many startups that face high churn rates and underestimate the variable costs associated with business operations, our approach has been carefully calibrated to mitigate these risks. Startups frequently encounter unexpected delays in development and unanticipated R&D expenses, which can significantly impact cash flow and scalability. We’ve strategically chosen to fund our R&D phase through founder and contact-based financing, allowing us to move forward with a robust foundation while minimizing unnecessary early-stage debt. As we transition into our initial full-scale launch, our focus is on revenue generation and subscriber growth, with minimal overheads that we’ve efficiently streamlined to under £30,000 per month.
Retain Gross Profit to Scale & Grow AI-Health
NEVER be reliant upon funding rounds to support artificial growth.
Investment capital in this round will be dedicated almost entirely to marketing, as our competitor analysis and market research indicate that a well-executed social media and digital marketing strategy yields substantial, predictable revenue growth. By directing funds primarily toward marketing rather than the “black holes” of R&D or inflated operating costs, we maximize the opportunity for immediate, revenue-generating impact. Our commitment is to maintain low overheads and reinvest revenue directly into expanding our marketing reach until we achieve our targeted subscription and investment milestones. With two revenue-ready apps and two more launching shortly, we’re positioned for controlled, sustainable growth that minimizes investor risk while supporting hyperscaling potential once we reach our key metrics. This pragmatic, streamlined approach ensures we are fully prepared to scale responsibly while capturing market opportunities.
Y1
Forecasted Revenue
2025-2026
FORECASTED
INVESTMENT RETURN
Forecasted
Upon a successful exit which is forecast to take place 12-18 months after our apps go live, an investment of £25,000 (£30m val) into AI-Health will return you:
EXIT
VALUE | RETURN
£150 m £125,000
£250 m £208,000
£400 m £333,000
£1 BN £830,000
£25,000 INVESTMENT
" 2 APPS NOW LIVE , 5 MORE READY TO RELEASE "
Press for Audio
AI-Health Investment Video
Low Risk
Hyper Scaling
Forecasted to achieve $100m GAR within 18 months (Our sector is booming 30%+ CAGR)
Strong FCF
Sustained .
Cash positive within 8 weeks. Low fixed costs, remain debt free, 7 apps generating revenue.
Live &
Accessible
As a business we follow European Sustainability Policy ethics , & everyone can gain free app access & health scoring with subscriptions at £12.99 /m
Sustained App
Growth
The mean average growth rates across Strava, Peloton, and Calm
Mean Year-on-Year Growth in Registered Users: 50.67%
WE TAKE PRIDE IN OUR NUMBERS
2.5k
SUBSCRIBERS TO BREAK-EVEN
£0
COMPANY IS DEBT FREE
5%
ACCURATE AS THE GOLD STANDARD
7 Apps
BUILT. REVENUE ENABLED.
100%
IP IS OWNED BY AI-HEALTH
AI-Health - Product Revenue
Our Revenue Model Explained: How Will We Earn Money?
-
App store subscriptions – AI Health enables consumers to download our applications for free but the free version doesn’t provide access to the entire programs within the apps.
-
To enjoy all of the chosen apps full library of programs - workouts, meditation and more, the app charges a subscription fee, which is the main contributor to the AI Health revenue stream.
-
Users can app choose from two subscription plans:
-
1. Monthly Subscription Plan: £ xxx per month
-
2. An Annual Subscription Plan: £ xxx per year
Scroll to learn about our product & capital timelines
Our Business Delivery
YEAR
2024
Oct
Walk Ailly App Soft launch
APP STORE LIVE
Dec
Fitness Ailly App - Pre Order
Via App Store
APP STORE : PRE ORDER LIVE
Explore Our Apps
7 Apps. - Developed, and ready to generate revenue, with world-class AI to help you become healthier.
Walk Ailly
Live: Now
Walk Ailly is the only walking app that can accurately record walking pace with precision location accuracy, helping to cut CVD by 50%. £12.99 m/o
Fitness Ailly
Live: Now
Advanced AI driven cardio app, with heart rate training, personalised in real-time to improve VO2 max fitness and performance.
£12.99 m/o
Run Ailly
Live: March 2025
Run Ailly; Learn how running can make you fitter, lose body fat or be coached to run a marathon. Clinically cccurate & engaging Design.
£12.99 m/o
Every 3 mins In The U.K.
Every 33 sec In The USA,
1 Person Dies from CVD Numbers are Rising, yet CVD is Preventable.
The Problem, MetS & CVD. These pandemics can be reversed & beat with efficient interventions.
Market Problem
Our Goal: Lower The Global CVD Risk
Health should be the priority of every human, but this generation is more clinically over weight, less active, less fit, with more inflammation than at any other point in our evolutionary history.
Apps are available on multiple devices but almost all fail to deliver measurable results, because they all neglect to factor global health.
Apple Watch 400 million have purchased one, with high expectations to help with their health and fitness, yet no purpose-built app exists on it, leaving many asking.. “Is this it ?"
HOW WE WILL HELP LOWER CVD RISK
- We have developed an advanced, accurate, simple to use & accessible walking intervention that will typically lower CVD risk by 40-47%
- Our Health Tests and base walking intervention will be free for all. This is our gift helping the world get better health.
Practical & Scientific
